Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.

Elmahashi MO, Elbareg AM, Essadi FM, Ashur BM, Adam I.

BMC Res Notes. 2014 Jan 9;7:23. doi: 10.1186/1756-0500-7-23.

2.

Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.

de Jong PG, Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S.

Cochrane Database Syst Rev. 2014 Jul 4;(7):CD004734. doi: 10.1002/14651858.CD004734.pub4. Review.

PMID:
24995856
3.

Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.

Areia AL, Fonseca E, Areia M, Moura P.

Arch Gynecol Obstet. 2016 Jan;293(1):81-6. doi: 10.1007/s00404-015-3782-2. Epub 2015 Jun 10.

PMID:
26059084
4.

Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.

Visser J, Ulander VM, Helmerhorst FM, Lampinen K, Morin-Papunen L, Bloemenkamp KW, Kaaja RJ.

Thromb Haemost. 2011 Feb;105(2):295-301. doi: 10.1160/TH10-05-0334. Epub 2010 Nov 23.

PMID:
21103659
5.

Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.

Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004734. doi: 10.1002/14651858.CD004734.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;7:CD004734.

PMID:
19160241
6.

Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome.

Alalaf S.

Arch Gynecol Obstet. 2012 Mar;285(3):641-7. doi: 10.1007/s00404-011-2055-y. Epub 2011 Aug 13.

7.

ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.

de Jong PG, Quenby S, Bloemenkamp KW, Braams-Lisman BA, de Bruin JP, Coomarasamy A, David M, DeSancho MT, van der Heijden OW, Hoek A, Hutten BA, Jochmans K, Koks CA, Kuchenbecker WK, Mol BW, Torrance HL, Scheepers HC, Stephenson MD, Verhoeve HR, Visser J, de Vries JI, Goddijn M, Middeldorp S.

Trials. 2015 May 7;16:208. doi: 10.1186/s13063-015-0719-9.

8.
9.

Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.

Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, Kingdom JC, Barrett J, Gent M.

J Rheumatol. 2009 Feb;36(2):279-87. doi: 10.3899/jrheum.080763).

PMID:
19208560
10.

Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.

Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS.

Thromb Haemost. 2000 May;83(5):693-7.

PMID:
10823264
12.

Protein S deficiency complicated pregnancy in women with recurrent pregnancy loss.

Shinozaki N, Ebina Y, Deguchi M, Tanimura K, Morizane M, Yamada H.

Gynecol Endocrinol. 2016 Aug;32(8):672-674. Epub 2016 Mar 3.

PMID:
26941215
13.

Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.

Mutlu I, Mutlu MF, Biri A, Bulut B, Erdem M, Erdem A.

Blood Coagul Fibrinolysis. 2015 Apr;26(3):267-73. doi: 10.1097/MBC.0000000000000219.

PMID:
25268607
14.

Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.

Fouda UM, Sayed AM, Abdou AM, Ramadan DI, Fouda IM, Zaki MM.

Int J Gynaecol Obstet. 2011 Mar;112(3):211-5. doi: 10.1016/j.ijgo.2010.09.010. Epub 2011 Jan 19.

PMID:
21251653
15.

Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone.

Sergio F, Maria Clara D, Gabriella F, Giorgia S, Sara De Carolis, Giancarlo P, Alessandro C.

Hypertens Pregnancy. 2006;25(2):115-27.

PMID:
16867918
16.

Low-molecular-weight heparin for thrombophilia in pregnant women.

Bar J, Cohen-Sacher B, Hod M, Blickstein D, Lahav J, Merlob P.

Int J Gynaecol Obstet. 2000 Jun;69(3):209-13.

PMID:
10854861
17.

Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.

Backos M, Rai R, Baxter N, Chilcott IT, Cohen H, Regan L.

Br J Obstet Gynaecol. 1999 Feb;106(2):102-7.

PMID:
10426674
18.

Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study.

Fawzy M, Shokeir T, El-Tatongy M, Warda O, El-Refaiey AA, Mosbah A.

Arch Gynecol Obstet. 2008 Jul;278(1):33-8. Epub 2007 Dec 11.

PMID:
18071727
19.

In vitro evidences of heparin's effects on embryo implantation and trophoblast development.

Tersigni C, Marana R, Santamarìa A, Castellani R, Scambia G, Simone ND.

Reprod Sci. 2012 May;19(5):454-62. doi: 10.1177/1933719111430994. Epub 2012 Feb 28. Review.

PMID:
22378860
20.

Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production.

Tulppala M, Marttunen M, Söderstrom-Anttila V, Foudila T, Ailus K, Palosuo T, Ylikorkala O.

Hum Reprod. 1997 Jul;12(7):1567-72.

PMID:
9262298

Supplemental Content

Support Center